CD8A and infection: SIVmac251-infected macaques were treated with a CD8-depleting antibody during acute infection to drive viral replication and cellular infection in the CNS, and were dosed with daily low (10 mg/kg) or high doses (30 mg/kg) of BLZ945 starting at day 10 postinfection and spanning 20–30 days.